Ovation Science (OVATF) AI Stock Analysis

Ovation Science

(Other OTC:OVATF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Proprietary Transdermal TechnologyA proprietary transdermal delivery approach can differentiate Ovation’s topical products from conventional formulations and provide a platform for multiple skin-related applications. If commercialization progresses, this technology-centered model may support repeat product development and longer-term competitive positioning.

Negative Factors

Persistent UnprofitabilityPersistent operating and net losses show that the business has not yet established a profitable operating model. Continued losses can restrict reinvestment, weaken financial resilience, and make future growth dependent on outside capital unless revenue and margins improve sustainably.

Ovation Science (OVATF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $288.31K
Dividend Yield: ―
Average Volume (3M): 1,206
Price to Earnings (P/E): -1.7
Beta (1Y): 0.82
Revenue Growth: -10.49%
EPS Growth: -36.17%
Country: US
Employees: 5
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Ovation Science Business Overview & Revenue Model

Company Description

Ovation Science Inc. specializes in the creation of cannabis and hemp-based products, distributed across Canada, the United States, and Mexico. A cornerstone of its offerings is Invisicare, a patented drug delivery technology employed in topical and...

Ovation Science Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

OVATF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:LABS	49Neutral	CAD 27.77M	-5.60	-13.79%	―	-6.74%	43.54%
TSE:VEXT	49Neutral	CAD 60.69M	-2.49	-25.01%	―	13.60%	11.06%
TSE:OILS	45Neutral	CAD 3.40M	-1.75	-43.92%	―	-18.30%	-397.37%
TSE:ATLE	42Neutral	CAD 41.96M	-0.76	-2099.75%	―	-100.00%	94.43%
TSE:BNXT	41Neutral	CAD 35.38M	-3.52	117.02%	―	―	―

* Healthcare Sector Average

Performance Comparison

OVATF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
OVATF	Ovation Science	0.04	0.01	33.33%
TSE:ATLE	Willow Biosciences	0.09	-0.07	-43.75%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-13.33%
TSE:OILS	Nextleaf Solutions	0.02	-0.04	-66.67%
TSE:VEXT	Vext Science	0.24	-0.03	-9.26%
TSE:BNXT	Bionxt Solutions Inc	0.26	-0.57	-68.67%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Ovation Science AI Stock Analysis